{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:27:33Z","timestamp":1794000453869,"version":"4.8.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK118072"],"award-info":[{"award-number":["R01DK118072"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG069010, U01AG077925"],"award-info":[{"award-number":["R01AG069010, U01AG077925"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA034196"],"award-info":[{"award-number":["P30CA034196"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F99CA284253"],"award-info":[{"award-number":["F99CA284253"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA034196"],"award-info":[{"award-number":["P30CA034196"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","award":["EvansMDS DRG"],"award-info":[{"award-number":["EvansMDS DRG"]}],"id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["CDP Fellow Award"],"award-info":[{"award-number":["CDP Fellow Award"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005946","name":"Jackson Laboratory","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/100005946","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Mark Foundation for Cancer Research and a Scholarship of Excellence Rafael del Pino"},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["953407"],"award-info":[{"award-number":["953407"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-203948, PJT-180406"],"award-info":[{"award-number":["PJT-203948, PJT-180406"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["Tier II CRC"],"award-info":[{"award-number":["Tier II CRC"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41556-026-02025-4","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:02:13Z","timestamp":1786006933000},"page":"1656-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stromal cell senescence augments haematopoietic cell fitness in clonal haematopoiesis"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-1284","authenticated-orcid":false,"given":"Jayna J.","family":"Mistry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-9793","authenticated-orcid":false,"given":"Kira A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Navarro Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibran","family":"Edun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia G.","family":"Aguilar-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Colom D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-4042","authenticated-orcid":false,"given":"Maria","family":"Telpoukhovskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Fern\u00e1ndez Maestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2708-887X","authenticated-orcid":false,"given":"Sheng F.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6276-8002","authenticated-orcid":false,"given":"Katharina S.","family":"G\u00f6tze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-1606","authenticated-orcid":false,"given":"Anastasia N.","family":"Tikhonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-1905","authenticated-orcid":false,"given":"Ross L.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-9504","authenticated-orcid":false,"given":"Jennifer J.","family":"Trowbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306\u2013313 (2012).","journal-title":"Nature"},{"key":"2025_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nm.3647","volume":"20","author":"A Mendelson","year":"2014","unstructured":"Mendelson, A. & Frenette, P. S. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat. Med. 20, 833\u2013846 (2014).","journal-title":"Nat. Med."},{"key":"2025_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal, S. & Ebert, E. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).","journal-title":"Science"},{"key":"2025_CR4","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1038\/s41375-020-01086-0","volume":"35","author":"EB van den Akker","year":"2021","unstructured":"van den Akker, E. B. et al. Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian. Leukemia 35, 2125\u20132129 (2021).","journal-title":"Leukemia"},{"key":"2025_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2025_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJMoa2413361","volume":"392","author":"O Pich","year":"2025","unstructured":"Pich, O. et al. Tumor-Infiltrating clonal hematopoiesis. N. Engl. J. Med. 392, 1594\u20131608 (2025).","journal-title":"N. Engl. J. Med."},{"key":"2025_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101989","volume":"6","author":"MM Buttigieg","year":"2025","unstructured":"Buttigieg, M. M., Vlasschaert, C., Bick, A. G., Vanner, R. J. & Rauh, M. J. Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes. Cell Rep. Med. 6, 101989 (2025).","journal-title":"Cell Rep. Med."},{"key":"2025_CR8","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood.V89.6.1870","volume":"89","author":"W Fiedler","year":"1997","unstructured":"Fiedler, W. et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89, 1870\u20131875 (1997).","journal-title":"Blood"},{"key":"2025_CR9","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1073\/pnas.191117498","volume":"98","author":"S Dias","year":"2001","unstructured":"Dias, S. et al. Inhibition of both paracrine and autocrine VEGF\/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc. Natl Acad. Sci. USA 98, 10857\u201310862 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2025_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1172\/JCI8978","volume":"106","author":"S Dias","year":"2000","unstructured":"Dias, S. et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J. Clin. Invest. 106, 511\u2013521 (2000).","journal-title":"J. Clin. Invest."},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1182\/blood.V95.1.309","volume":"95","author":"JW Hussong","year":"2000","unstructured":"Hussong, J. W., Rodgers, G. M. & Shami, P. J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95, 309\u2013313 (2000).","journal-title":"Blood"},{"key":"2025_CR12","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2025_CR13","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41375-018-0368-6","volume":"33","author":"MA Loberg","year":"2019","unstructured":"Loberg, M. A. et al. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Leukemia 33, 1635\u20131649 (2019).","journal-title":"Leukemia"},{"key":"2025_CR14","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424\u20132433 (2010).","journal-title":"N. Engl. J. Med."},{"key":"2025_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1182\/blood.2024024275","volume":"144","author":"KA Young","year":"2024","unstructured":"Young, K. A. et al. Variation in mesenchymal KITL\/SCF and IGF1 expression in middle age underlies steady-state hematopoietic stem cell aging. Blood 144, 378\u2013391 (2024).","journal-title":"Blood"},{"key":"2025_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2011","unstructured":"Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23\u201331 (2011).","journal-title":"Nat. Genet."},{"key":"2025_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.exphem.2022.06.001","volume":"112-113","author":"DE Morales-Mantilla","year":"2022","unstructured":"Morales-Mantilla, D. E. & King, K. Y. FGD5 marks a subpopulation of hematopoietic stem and progenitor cells that resist interferon-gamma-mediated differentiation. Exp. Hematol. 112-113, 35\u201343 (2022).","journal-title":"Exp. Hematol."},{"key":"2025_CR18","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1038\/onc.2008.213","volume":"27","author":"AL Fridman","year":"2008","unstructured":"Fridman, A. L. & Tainsky, M. A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene 27, 5975\u20135987 (2008).","journal-title":"Oncogene"},{"key":"2025_CR19","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","volume":"187","author":"S Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay, S. et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell 187, 3120\u20133140.e3129 (2024).","journal-title":"Cell"},{"key":"2025_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65802-z","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. An inflammatory T-cell-stromal axis contributes to hematopoietic stem\/progenitor cell failure and clonal evolution in human myelodysplastic syndrome. Nat. Commun. 16, 10041 (2025).","journal-title":"Nat. Commun."},{"key":"2025_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65803-y","volume":"16","author":"KD Prummel","year":"2025","unstructured":"Prummel, K. D. et al. Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia. Nat. Commun. 16, 10042 (2025).","journal-title":"Nat. Commun."},{"key":"2025_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215148","volume":"15","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Inflammatory bone marrow mesenchymal stem cells in multiple myeloma: transcriptional signature and in vitro modeling. Cancers (Basel) 15, 5148 (2023).","journal-title":"Cancers (Basel)"},{"key":"2025_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41556-022-01053-0","volume":"25","author":"CA Mitchell","year":"2023","unstructured":"Mitchell, C. A. et al. Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat. Cell Biol. 25, 30\u201341 (2023).","journal-title":"Nat. Cell Biol."},{"key":"2025_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1182\/blood.2025029513","volume":"147","author":"JW Swann","year":"2026","unstructured":"Swann, J. W. et al. Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche. Blood 147, 739\u2013754 (2026).","journal-title":"Blood"},{"key":"2025_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41580-024-00738-8","volume":"25","author":"V Suryadevara","year":"2024","unstructured":"Suryadevara, V. et al. SenNet recommendations for detecting senescent cells in different tissues. Nat. Rev. Mol. Cell Biol. 25, 1001\u20131023 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2025_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI195772","volume":"136","author":"ML Doolittle","year":"2026","unstructured":"Doolittle, M. L. et al. Aged murine bone marrow myeloid and mesenchymal cells develop unique senescence phenotypes. J. Clin. Invest. 136, e195772 (2026).","journal-title":"J. Clin. Invest."},{"key":"2025_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40393-9","volume":"14","author":"ML Doolittle","year":"2023","unstructured":"Doolittle, M. L. et al. Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton. Nat. Commun. 14, 4587 (2023).","journal-title":"Nat. Commun."},{"key":"2025_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y. et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15, 428\u2013435 (2016).","journal-title":"Aging Cell"},{"key":"2025_CR29","doi-asserted-by":"publisher","first-page":"8155","DOI":"10.18632\/oncotarget.2692","volume":"6","author":"N Alessio","year":"2015","unstructured":"Alessio, N. et al. Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process. Oncotarget 6, 8155\u20138166 (2015).","journal-title":"Oncotarget"},{"key":"2025_CR30","first-page":"5414","volume":"63","author":"A Meng","year":"2003","unstructured":"Meng, A., Wang, Y., Van Zant, G. & Zhou, D. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 63, 5414\u20135419 (2003).","journal-title":"Cancer Res."},{"key":"2025_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","volume":"20","author":"K Moran-Crusio","year":"2011","unstructured":"Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11\u201324 (2011).","journal-title":"Cancer Cell"},{"key":"2025_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.stemcr.2015.08.018","volume":"5","author":"MG Poulos","year":"2015","unstructured":"Poulos, M. G. et al. Vascular platform to define hematopoietic stem cell factors and enhance regenerative hematopoiesis. Stem Cell Rep. 5, 881\u2013894 (2015).","journal-title":"Stem Cell Rep."},{"key":"2025_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022).","journal-title":"Nat. Commun."},{"key":"2025_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.stem.2014.07.005","volume":"15","author":"N Cabezas-Wallscheid","year":"2014","unstructured":"Cabezas-Wallscheid, N. et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell 15, 507\u2013522 (2014).","journal-title":"Cell Stem Cell"},{"key":"2025_CR35","doi-asserted-by":"crossref","unstructured":"Jassinskaja, M. et al. Selection of pre-leukemic hematopoietic stem cells driven by distinct extracellular matrix molecules. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2025.01.20.633881v1 (2025).","DOI":"10.1101\/2025.01.20.633881"},{"key":"2025_CR36","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.joca.2021.02.075","volume":"29","author":"S Ashraf","year":"2021","unstructured":"Ashraf, S., Santerre, P. & Kandel, R. TNF-\u03b1 activates STAT3 signaling and senescence in NP cells. Osteoarthr. Cartil. 29, S51\u2013S52 (2021).","journal-title":"Osteoarthr. Cartil."},{"key":"2025_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2024.110800","volume":"116","author":"X Pang","year":"2024","unstructured":"Pang, X. et al. Identification of STAT3 as a biomarker for cellular senescence in liver fibrosis: a bioinformatics and experimental validation study. Genomics 116, 110800 (2024).","journal-title":"Genomics"},{"key":"2025_CR38","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41419-022-05207-8","volume":"13","author":"H-J Cho","year":"2022","unstructured":"Cho, H.-J. et al. Nintedanib induces senolytic effect via STAT3 inhibition. Cell Death Dis. 13, 760 (2022).","journal-title":"Cell Death Dis."},{"key":"2025_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.intimp.2008.01.013","volume":"8","author":"KJ Grattendick","year":"2008","unstructured":"Grattendick, K. J., Nakashima, J. M., Feng, L., Giri, S. N. & Margolin, S. B. Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro. Int. Immunopharmacol. 8, 679\u2013687 (2008).","journal-title":"Int. Immunopharmacol."},{"key":"2025_CR40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0161-5890(91)90004-4","volume":"28","author":"J Wijdenes","year":"1991","unstructured":"Wijdenes, J. et al. Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. Mol. Immunol. 28, 1183\u20131192 (1991).","journal-title":"Mol. Immunol."},{"key":"2025_CR41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13, 1235\u20131242 (2006).","journal-title":"Chem. Biol."},{"key":"2025_CR42","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31, 722\u2013733 (2014).","journal-title":"Dev. Cell"},{"key":"2025_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13287-022-02901-4","volume":"13","author":"Y Miura","year":"2022","unstructured":"Miura, Y., Endo, K., Komori, K. & Sekiya, I. Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients. Stem Cell Res. Ther. 13, 222 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"2025_CR44","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072\u20131079 (2017).","journal-title":"Nat. Med."},{"key":"2025_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1182\/blood-2018-04-845420","volume":"133","author":"AM Abdul-Aziz","year":"2019","unstructured":"Abdul-Aziz, A. M. et al. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment. Blood 133, 446\u2013456 (2019).","journal-title":"Blood"},{"key":"2025_CR46","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3324\/haematol.2017.172429","volume":"103","author":"MK Steven","year":"2018","unstructured":"Steven, M. K. et al. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival. Haematologica 103, 810\u2013821 (2018).","journal-title":"Haematologica"},{"key":"2025_CR47","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.ccell.2024.10.009","volume":"42","author":"RL Bowman","year":"2024","unstructured":"Bowman, R. L. et al. In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy. Cancer Cell 42, 1955\u20131969 e1957 (2024).","journal-title":"Cancer Cell"},{"key":"2025_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1158\/2643-3230.BCD-23-0043","volume":"4","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML. Blood Cancer Discovery 4, 394\u2013417 (2023).","journal-title":"Blood Cancer Discovery"},{"key":"2025_CR49","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/2159-8290.CD-22-0086","volume":"12","author":"JM SanMiguel","year":"2022","unstructured":"SanMiguel, J. M. et al. Distinct tumor necrosis factor alpha receptors dictate stem cell fitness versus lineage output in Dnmt3a-mutant clonal hematopoiesis. Cancer Discov. 12, 2763\u20132773 (2022).","journal-title":"Cancer Discov."},{"key":"2025_CR50","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.aba9304","volume":"374","author":"S Avagyan","year":"2021","unstructured":"Avagyan, S. et al. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science 374, 768\u2013772 (2021).","journal-title":"Science"},{"key":"2025_CR51","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","volume":"28","author":"D Hormaechea-Agulla","year":"2021","unstructured":"Hormaechea-Agulla, D. et al. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNgamma signaling. Cell Stem Cell 28, 1428\u20131442 e1426 (2021).","journal-title":"Cell Stem Cell"},{"key":"2025_CR52","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41375-025-02621-7","volume":"39","author":"N Plakhova","year":"2025","unstructured":"Plakhova, N. et al. Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma. Leukemia 39, 1464\u20131475 (2025).","journal-title":"Leukemia"},{"key":"2025_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","volume":"59","author":"SO Abegunde","year":"2018","unstructured":"Abegunde, S. O., Buckstein, R., Wells, R. A. & Rauh, M. J. An inflammatory environment containing TNFalpha favors Tet2-mutant clonal hematopoiesis. Exp. Hematol. 59, 60\u201365 (2018).","journal-title":"Exp. Hematol."},{"key":"2025_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43697-y","volume":"14","author":"J McClatchy","year":"2023","unstructured":"McClatchy, J. et al. Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells. Nat. Commun. 14, 8102 (2023).","journal-title":"Nat. Commun."},{"key":"2025_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","volume":"23","author":"Z Cai","year":"2018","unstructured":"Cai, Z. et al. Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis. Cell Stem Cell 23, 833\u2013849 e835 (2018).","journal-title":"Cell Stem Cell"},{"key":"2025_CR56","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel, M. et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557, 580\u2013584 (2018).","journal-title":"Nature"},{"key":"2025_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.stem.2024.05.010","volume":"31","author":"NA Jakobsen","year":"2024","unstructured":"Jakobsen, N. A. et al. Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging. Cell Stem Cell 31, 1127\u20131144 e1117 (2024).","journal-title":"Cell Stem Cell"},{"key":"2025_CR58","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1038\/s44319-026-00802-8","volume":"27","author":"N Hori","year":"2026","unstructured":"Hori, N. et al. Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells. EMBO Rep. 27, 3547\u20133563 (2026).","journal-title":"EMBO Rep."},{"key":"2025_CR59","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/aac2.12037","volume":"2","author":"EJ Evans Jr","year":"2021","unstructured":"Evans, E. J. Jr & DeGregori, J. Cells with cancer-associated mutations overtake our tissues as we age. Aging Cancer 2, 82\u201397 (2021).","journal-title":"Aging Cancer"},{"key":"2025_CR60","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","volume":"28","author":"S Chaib","year":"2022","unstructured":"Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: the path to the clinic. Nat. Med. 28, 1556\u20131568 (2022).","journal-title":"Nat. Med."},{"key":"2025_CR61","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","volume":"4","author":"C Amor","year":"2024","unstructured":"Amor, C. et al. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Nat. Aging 4, 336\u2013349 (2024).","journal-title":"Nat. Aging"},{"key":"2025_CR62","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.7660125","volume":"269","author":"R Kuhn","year":"1995","unstructured":"Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427\u20131429 (1995).","journal-title":"Science"},{"key":"2025_CR63","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1084\/jem.20130428","volume":"211","author":"R Gazit","year":"2014","unstructured":"Gazit, R. et al. Fgd5 identifies hematopoietic stem cells in the murine bone marrow. J. Exp. Med. 211, 1315\u20131331 (2014).","journal-title":"J. Exp. Med."},{"key":"2025_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"2025_CR65","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1182\/blood-2004-08-3037","volume":"105","author":"JR Gothert","year":"2005","unstructured":"Gothert, J. R. et al. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105, 2724\u20132732 (2005).","journal-title":"Blood"},{"key":"2025_CR66","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.celrep.2012.07.004","volume":"2","author":"Z Lao","year":"2012","unstructured":"Lao, Z., Raju, G. P., Bai, C. B. & Joyner, A. L. MASTR: a technique for mosaic mutant analysis with spatial and temporal control of recombination using conditional floxed alleles in mice. Cell Rep. 2, 386\u2013396 (2012).","journal-title":"Cell Rep."},{"key":"2025_CR67","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/ng.796","volume":"43","author":"GS Vassiliou","year":"2011","unstructured":"Vassiliou, G. S. et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat. Genet. 43, 470\u2013475 (2011).","journal-title":"Nat. Genet."},{"key":"2025_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.stem.2007.03.002","volume":"1","author":"Y Ruzankina","year":"2007","unstructured":"Ruzankina, Y. et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1, 113\u2013126 (2007).","journal-title":"Cell Stem Cell"},{"key":"2025_CR69","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature11323","volume":"488","author":"M Sasaki","year":"2012","unstructured":"Sasaki, M. et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656\u2013659 (2012).","journal-title":"Nature"},{"key":"2025_CR70","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ng.115","volume":"40","author":"KM Haigis","year":"2008","unstructured":"Haigis, K. M. et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat. Genet. 40, 600\u2013608 (2008).","journal-title":"Nat. Genet."},{"key":"2025_CR71","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1182\/blood.2020010163","volume":"138","author":"JS Hecker","year":"2021","unstructured":"Hecker, J. S. et al. CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease. Blood 138, 1727\u20131732 (2021).","journal-title":"Blood"},{"key":"2025_CR72","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1101\/gr.147686.112","volume":"23","author":"JB Hiatt","year":"2013","unstructured":"Hiatt, J. B., Pritchard, C. C., Salipante, S. J., O\u2019Roak, B. J. & Shendure, J. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res. 23, 843\u2013854 (2013).","journal-title":"Genome Res."},{"key":"2025_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","journal-title":"Gigascience"},{"key":"2025_CR74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2025_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"2025_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2025_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"Gene Ontology Consortium et al.","year":"2023","unstructured":"Gene Ontology Consortium et al. The Gene Ontology knowledgebase in 2023. Genetics 224, iyad031 (2023).","journal-title":"Genetics"},{"key":"2025_CR78","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"2025_CR79","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2025_CR80","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2025_CR81","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","volume":"15","author":"BO Zhou","year":"2014","unstructured":"Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G. & Morrison, S. J. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15, 154\u2013168 (2014).","journal-title":"Cell Stem Cell"},{"key":"2025_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02660-8","volume":"23","author":"A Janjic","year":"2022","unstructured":"Janjic, A. et al. Prime-seq, efficient and powerful bulk RNA sequencing. Genome Biol. 23, 88 (2022).","journal-title":"Genome Biol."},{"key":"2025_CR83","first-page":"26","volume":"3","author":"S Huang","year":"2015","unstructured":"Huang, S. et al. An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J. Orthop. Transl. 3, 26\u201333 (2015).","journal-title":"J. Orthop. Transl."},{"key":"2025_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103009","volume":"5","author":"OG Idelfonso-Garc\u00eda","year":"2024","unstructured":"Idelfonso-Garc\u00eda, O. G. et al. Protocol to detect senescence-associated \u03b2-galactosidase and immunoperoxidase activity in fresh-frozen murine tissues. STAR Protoc. 5, 103009 (2024).","journal-title":"STAR Protoc."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02025-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:02:59Z","timestamp":1786374179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02025-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-02025-4","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.F.C. is a consultant for Daiichi-Sankyo and Ursamin. He was previously a consultant for Dava Oncology and held equity interest in Imago Biosciences, neither of which are directly related to the content of this paper. R.L.L. is a former member of the Supervisory Board and current SAB member for Qiagen (compensation\/equity), a co-founder at Ajax (equity), a board member of the Mark Foundation for Cancer Research and a former scientific advisor to Mission Bio, Kurome, Syndax, Scorpion, Zentalis, Jubilant, Auron, Prelude and C4 Therapeutics; for each of these entitites he received equity\/compensation. He has received research support from the Cure Breast Cancer Foundation (with IP rights), Calico, Zentalis and Ajax, and has consulted\/provided professional services for ECOG-ACRIN, Genome Canada, Goldman Sachs and Astra Zeneca. J.J.T. has previously received research support from H3 Biomedicine, and patent royalties from Fate Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}